Catheter ablation of atrial fibrillation: Randomized controlled trials and registries, a look back and the view forward

Journal of Interventional Cardiac Electrophysiology

Volumn 31, Issue 1, 2011, Pages 69-80

  Santangeli, Pasquale ^a,c   Di Biase, Luigi ^a,b,e   Pelargonio, Gemma ^c   Dello Russo, Antonio ^d   Casella, Michela ^d   Sanchez, Javier ^a   Horton, Rodney ^a   Gallinghouse, G Joseph ^a   Natale, Andrea ^a,b,f,g,h  

^a TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^b The University of Texas at Austin   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

^f STANFORD UNIVERSITY   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h SCRIPPS CLINIC   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Randomized controlled trial; Registry

Indexed keywords

WARFARIN;

ARTICLE; CATHETER ABLATION; DISEASE REGISTRY; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEMATOTHORAX; HEMOPERICARDIUM; HUMAN; MORBIDITY; MORTALITY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROPERITONEAL HEMORRHAGE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CHRONIC DISEASE; HUMANS; MORBIDITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES;

EID: 79959570034     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-011-9562-4     Document Type: Article

References (59)

1. Braunwald, E. (1997). Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. The New England Journal of Medicine, 337, 1360-1369.
2. Wolf, P. A., Benjamin, E. J., Belanger, A. J., Kannel, W. B., Levy, D., & D'Agostino, R. B. (1996). Secular trends in the prevalence of atrial fibrillation: The Framingham Study. American Heart Journal, 131, 790-795.
3. Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998). Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. The American Journal of Cardiology, 82, 2N-9N.
4. Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A., & Cuddy, T. E. (1995). The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. The American Journal of Medicine, 98, 476-484.
5. Wolf, P. A., Mitchell, J.B., Baker, C. S., Kannel, W.B.,&D'Agostino, R. B. (1998). Impact of atrial fibrillation on mortality, stroke, and medical costs. Archives of Internal Medicine, 158, 229-234.
6. Le Heuzey, J. Y., Paziaud, O., Piot, O., Said, M. A., Copie, X., Lavergne, T., et al. (2004). Cost of care distribution in atrial fibrillation patients: the COCAF study. American Heart Journal, 147, 121-126.
7. Wazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., et al. (2005). Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA, 293, 2634-2640.
8. Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., et al. (2010). Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. The Journal of the American Medical Association, 303, 333-340.
9. Oral, H., Scharf, C., Chugh, A., Hall, B., Cheung, P., Good, E., et al. (2003). Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation, 108, 2355-2360.
10. Nakagawa, H., Scherlag, B. J., Lockwood, D. J., Wolf, R. K., Peyton, M., Wu, R., et al. (2005). Localization of left atrial autonomic ganglionated plexuses using endocardial and epicardial high frequency stimulation in patients with atrial fibrillation. Heart Rhythm, 2, S10.
11. Pappone, C., Santinelli, V., Manguso, F., Vicedomini, G., Gugliotta, F., Augello, G., et al. (2004). Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation, 109, 327-334.
12. Marrouche, N. F., Martin, D. O., Wazni, O., Gillinov, A. M., Klein, A., Bhargava, M., et al. (2003). Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation, 107, 2710-2716.
13. Pachon, M. J., Pachon, M. E., Lobo, T. J., Pachon, M. Z., Vargas, R. N., Pachon, D. Q., et al. (2004). A new treatment for atrial fibrillation based on spectral analysis to guide the catheter RFablation. Europace, 6, 590-601.
14. Haissaguerre, M., Jais, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England Journal of Medicine, 339, 659-666.
15. Elayi, C. S., Di Biase, L., Barrett, C., Ching, C. K., al Aly, M., Lucciola, M., et al. (2010). Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm, 7, 1216-1223.
16. Nademanee, K., McKenzie, J., Kosar, E., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., et al. (2004). A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. Journal of the American College of Cardiology, 43, 2044-2053.
17. Di Biase, L., Burkhardt, J. D., Mohanty, P., Sanchez, J., Mohanty, S., Horton, R., et al. (2010). Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation, 122, 109-118.
18. Jais, P., Cauchemez, B., Macle, L., Daoud, E., Khairy, P., Subbiah, R., et al. (2008). Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation, 118, 2498-2505.
19. U.S. National Institutes of Health (2009) Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). http://www.clinicaltrials.gov/.
20. U.S. National Institutes of Health (2006) First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study). http://www.clinicaltrials.gov/.
21. U.S National Institutes of Health (2005) Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation (MANTRA-PAF). http://www.clinicaltrials.gov/.
22. Al-Khatib, S. M., Calkins, H., Eloff, B. C., Packer, D. L., Ellenbogen, K. A., Hammill, S. C., et al. (2010). Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium BIncubator" Think Tank. American Heart Journal, 159, 17-24.
23. Arruda, M., Mlcochova, H., Prasad, S. K., Kilicaslan, F., Saliba, W., Patel, D., et al. (2007). Electrical isolation of the superior vena cava: an adjunctive strategy to pulmonary vein antrum isolation improving the outcome of AF ablation. Journal of Cardiovascular Electrophysiology, 18, 1261-1266. (Pubitemid 350115776)
24. Marrouche, N. F., Dresing, T., Cole, C., Bash, D., Saad, E., Balaban, K., et al. (2002). Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. Journal of the American College of Cardiology, 40, 464-474. (Pubitemid 34833161)
25. Verma, A., Marrouche, N. F., & Natale, A. (2004). Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique. Journal of Cardiovascular Electrophysiology, 15, 1335-1340. (Pubitemid 39612646)
26. Chen, S. A., Hsieh, M. H., Tai, C. T., Tsai, C. F., Prakash, V. S., Yu, W. C., et al. (1999). Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation, 100, 1879-1886. (Pubitemid 29511141)
27. Gerstenfeld, E. P., Guerra, P., Sparks, P. B., Hattori, K., & Lesh, M. D. (2001). Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. Journal of Cardiovascular Electrophysiology, 12, 900-908. (Pubitemid 32751900)
28. Saad, E. B., Marrouche, N. F., & Natale, A. (2002). Ablation of atrial fibrillation. Current Cardiology Reports, 4, 379-387.
29. Kanagaratnam, L., Tomassoni, G., Schweikert, R., Pavia, S., Bash, D., Beheiry, S., et al. (2001). Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing and Clinical Electrophysiology, 24, 1774-1779. (Pubitemid 34066782)
30. Haissaguerre, M., Shah, D. C., Jais, P., Hocini, M., Yamane, T., Deisenhofer, I., et al. (2000). Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation, 102, 2463-2465.
31. Khaykin, Y., Skanes, A., Champagne, J., Themistoclakis, S., Gula, L., Rossillo, A., et al. (2009). A randomized controlled trial of the efficacy and safety of electroanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasound. Circ Arrhythm Electrophysiology, 2, 481-487.
32. Bhargava, M., Di Biase, L., Mohanty, P., Prasad, S., Martin, D. O., Williams-Andrews, M., et al. (2009). Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm, 6, 1403-1412.
33. Di Biase, L., Elayi, C. S., Fahmy, T. S., Martin, D. O., Ching, C. K., Barrett, C., et al. (2009). Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ Arrhythm Electrophysiology, 2, 113-119.
34. Karch, M. R., Zrenner, B., Deisenhofer, I., Schreieck, J., Ndrepepa, G., Dong, J., et al. (2005). Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation, 111, 2875-2880. (Pubitemid 40814179)
35. Corrado, A., Bonso, A., Madalosso, M., Rossillo, A., Themistoclakis, S., Di Biase, L., et al. (2010). Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study. Journal of Cardiovascular Electrophysiology, 21, 1-5.
36. Nattel, S., Burstein, B., & Dobrev, D. (2008). Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiology, 1, 62-73.
37. Elayi, C. S., Verma, A., Di Biase, L., Ching, C. K., Patel, D., Barrett, C., et al. (2008). Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm, 5, 1658-1664.
38. Haissaguerre, M., Hocini, M., Sanders, P., Sacher, F., Rotter, M., Takahashi, Y., et al. (2005). Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. Journal of Cardiovascular Electrophysiology, 16, 1138-1147.
39. Haissaguerre, M., Sanders, P., Hocini, M., Takahashi, Y., Rotter, M., Sacher, F., et al. (2005). Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. Journal of Cardiovascular Electrophysiology, 16, 1125-1137.
40. Scherlag, B. J., Yamanashi, W., Patel, U., Lazzara, R., & Jackman, W. M. (2005). Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. Journal of the American College of Cardiology, 45, 1878-1886. (Pubitemid 40779871)
41. Nakagawa, H., Jackman, W. M., Scherlag, B. J., Yokoyama, K., Wu, R., Oza, S., et al. (2005). Relationship of complex fractionated atrial electrograms during atrial fibrillation to the location of cardiac automatic ganglionated plexi in patients with atrial fibrillation. Circulation, 112, II-746.
42. Hwang, C., Wu, T. J., Doshi, R. N., Peter, C. T.,&Chen, P. S. (2000). Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation. Circulation, 101, 1503-1505.
43. Jais, P., Haissaguerre, M., Shah, D. C., Chouairi, S., Gencel, L., Hocini, M., et al. (1997). A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation, 95, 572-576. (Pubitemid 27063030)
44. Di Biase, L., Burkhardt, J. D., Mohanty, P., Sanchez, J., Horton, R., Gallinghouse, G. J., et al. (2010). Periprocedural stroke and management ofmajor bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation, 121, 2550-2556.
45. Hussein, A. A., Martin, D. O., Saliba, W., Patel, D., Karim, S., Batal, O., et al. (2009). Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm, 6, 1425-1429.
46. Packer, D. (2010) Sustained treatment of paroxysmal atrial fibrillation (STOP-AF). Presented at the ACC 2010 Annual Meeting. Atlanta, GA
47. U.S. National Institutes of Health (2008) Ablation vs Amiodarone for Treatment of AFib in Patients with CHF and an ICD (AATAC-HF). http://www.clinicaltrials.gov/.
48. U.S. National Institutes of Health (2008) Catheter Ablation Versus Standard Conventional Treatment in Patients With Left Ventricular Dysfunction and Atrial Fibrillation (CASTLE-AF). http://www.clinicaltrials.gov/.
49. Chen, M. S., Marrouche, N. F., Khaykin, Y., Gillinov, A. M., Wazni, O., Martin, D. O., et al. (2004). Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. Journal of the American College of Cardiology, 43, 1004-1009. (Pubitemid 38352980)
50. Khan, M. N., Jais, P., Cummings, J., Di Biase, L., Sanders, P., Martin, D. O., et al. (2008). Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. The New England Journal of Medicine, 359, 1778-1785.
51. Khaykin, Y., Marrouche, N. F., Saliba, W., Schweikert, R., Bash, D., Chen, M. S., et al. (2004). Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm, 1, 33-39. (Pubitemid 38647246)
52. Verma, A., Wazni, O. M., Marrouche, N. F., Martin, D. O., Kilicaslan, F., Minor, S., et al. (2005). Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. Journal of the American College of Cardiology, 45, 285-292. (Pubitemid 40094739)
53. Packer, D. (2010) Catheter Ablation vs. Anti-arrhythmic Drug Therapy for Atrial Fibrillation (CABANA). Presented at the ACC 2010 Annual Meeting. Atlanta, GA.
54. (2009) Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation (SARA). http://clinicaltrials.gov/.
55. U.S. National Institutes of Health (2010) Safety and Efficacy Study of the Combined Ablation Procedure to Treat Longstanding Persistent Atrial Fibrillation (CAPstopsLSPAF). http://clinicaltrials.gov/.
56. Di Biase, L., Bailey, S., Kiser, A.C., Horton, R., Sanchez, J., Burkhardt, D., et al. (2010). Long term results of the convergent endo-epicardial ablation procedure for the treatment of long-standing persistent atrial fibrillation. Heart Rhythm, 7, S13.
57. Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994). Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation, 89, 224-227. (Pubitemid 24026493)
58. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946-952. (Pubitemid 28446646)
59. U.S. National Institutes of Health (2005) Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation (MANTRA-PAF). http://clinicaltrials.gov/.